Join Us At EACR 2025!

EditCo Sponsored Industry Symposium

Title: Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering

This symposium features thought leaders in molecular oncology, gene editing, and computational biology, highlighting how CRISPR technologies are transforming cancer research.

Session Overview:

• Dr. Simon Lebaron, Centre de Biologie Intégrative, University of Toulouse
  Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

  Related Case Study:

  Rapid, Reliable Knockouts for Cancer Biology with XDel Technology: Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

• Dr. Daniel Miller, Evariste
  AI-Driven Identification and Validation of Novel Synthetic Lethal Gene Pairs

• Dr. Amalia Soenens, EditCo Bio
  Leveraging an Advanced CRISPR Platform to Streamline Oncology Breakthroughs

Featured Poster Presentation

Title: HiBiT-Tagged CRISPR Cell Line Engineering: Enabling Antibody-Free Protein Quantification and Targeted Degradation Analysis in Cancer Research

Session: Cancer Cell Biology

Date: June 18, 2025

Time: 10:45 – 20:00

Stop by to learn how our HiBiT knock-in cell line service enables highly sensitive, real-time protein monitoring—ideal for functional genomics, targeted protein degradation, and other cancer research applications.